Global biotechnology and medical device corporation NanoEntek will incorporate AAI Healthcare as a 100% subsidiary through a comprehensive stock exchange, it announced on the 11th.
NanoEntek explained that it decided to pursue this stock exchange to respond to the shift in the healthcare paradigm focused on prevention and early diagnosis. The company plans to proactively discover new business areas that respond to advancements in non-contact telemedicine by integrating the core competencies of both companies.
AAI Healthcare is a total healthcare service specialist with strengths in healthcare consulting, screening and treatment linkage services, and operating digital healthcare platforms.
NanoEntek will take charge of hardware-focused businesses, such as supplying existing diagnostic devices and kits. In collaboration with AAI Healthcare, it aims to provide integrated solutions that cover the entire healthcare process, combining digital platforms with medical networks.
In the future, NanoEntek plans to pursue innovative healthcare services, including the development of artificial intelligence (AI)-based medical record analysis solutions and the discovery of new business opportunities based on medical data and user data, together with AAI Healthcare.
A representative from NanoEntek noted, "Through the incorporation of AAI Healthcare, we will complete the healthcare value chain, covering everything from diagnosis to consulting and aftercare, while enhancing our competitiveness in the telemedicine and digital healthcare industries. We aim to achieve sustainable growth and increase corporate value in the future healthcare market through this stock exchange."